Expert Perspectives

Use the tool below to view all available Global Neurology Academy Series

Treatment of Progressive MS: Why, Who, When, How
Treatment of Progressive MS: Why, Who, When, How
Resources
Treatment of Progressive MS: Why, Who, When, How
- Giancarlo Comi, MD
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Resources
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Resources
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CE
The Diagnostic Challenges of Spinal Cord Lesions in MS
- Jiwon Oh, MD, PhD, FRCPC
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Resources
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Reducing the Burden of MS Treatment
Reducing the Burden of MS Treatment
Resources
Reducing the Burden of MS Treatment
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Resources
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Multiple Sclerosis Physician Resources
Multiple Sclerosis Physician Resources
Resources
Multiple Sclerosis Physician Resources
Immunologic Effects on Metabolic Syndrome and MS
Immunologic Effects on Metabolic Syndrome and MS
Interviews
Immunologic Effects on Metabolic Syndrome and MS
Establishing Partnerships to Optimize Patient Outcomes
Establishing Partnerships to Optimize Patient Outcomes
Interviews
Establishing Partnerships to Optimize Patient Outcomes
Highlights from the MAGNIMS Consensus Guidelines
Highlights from the MAGNIMS Consensus Guidelines
Interviews
Highlights from the MAGNIMS Consensus Guidelines
Current and Future MS Treatment Options
Current and Future MS Treatment Options
CME/CE
Current and Future MS Treatment Options
The Value of Biomarkers in MS Patients
The Value of Biomarkers in MS Patients
Interviews
The Value of Biomarkers in MS Patients
Determining an MS Patient's Long-Term Prognosis
Determining an MS Patient's Long-Term Prognosis
CME/CE
Determining an MS Patient's Long-Term Prognosis
Current Landscape of MS Diagnosis/Prognosis
Current Landscape of MS Diagnosis/Prognosis
CME/CE
Current Landscape of MS Diagnosis/Prognosis
Emerging MRI Techniques in MS Patients
Emerging MRI Techniques in MS Patients
CME/CE
Emerging MRI Techniques in MS Patients

Expert Perspectives

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Expert Perspectives

Popular

Title

Share on ReachMD